UNITED STATES

                       SECURITIES AND EXCHANGE COMMISSION

                              Washington, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

                          Date of Report: July 31, 2007
                (Date of earliest event reported): July 26, 2007

                                 Gene Logic Inc.

               (Exact Name of Registrant as Specified in Charter)


        Delaware                        0-23317                 06-1411336
(State or other jurisdiction    (Commission File Number)       (IRS Employer
    of incorporation)                                        Identification No.)



  50 West Watkins Mill Road, Gaithersburg, Maryland               20878
        (Address of principal executive office)                 (Zip Code)


       Registrant's telephone number, including area code: (301) 987-1700

                                       N/A
          (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligations of the registrant under any of the
following provisions (see General Instruction A.2. below):


[ ]  Written communication pursuant to Rule 425 under the Securities Act
     (17 CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act
     (17 CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.135-4(c))


Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB control number.



Item 5.02       Departure of Directors or Principal Officers; Election of
                Directors; Appointment of Certain Officers; Compensatory
                Arrangements of Certain Officers.

For her performance in 2007, on July 26, 2007, the Board of Directors awarded
Dr. Joanne-Smith-Farrell, Senior Vice President of Business Development and
Licensing, a bonus of $20,000.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                        GENE LOGIC INC.

Date: July 31, 2007                     By: /s/ Charles L. Dimmler, III.
                                            ----------------------------
                                            Charles L. Dimmler, III
                                            Chief Executive Officer